Remedium Retatrutide 50mg Pen – Triple Agonist Research Compound

The Remedium Retatrutide 50mg Pen is a high-concentration investigational peptide device formulated for advanced laboratory and metabolic research applications. This prefilled pen contains Retatrutide in a stabilised and pH-balanced solution designed for precision dosing protocols.

Retatrutide is researched for its activity across GLP-1, GIP and glucagon receptor pathways. The convenient flexipen system removes the need for reconstitution while supporting accurate and repeatable administration in controlled research environments.

Key Features

• 50mg total Retatrutide peptide content
• Triple agonist investigational compound
• GLP-1, GIP and glucagon receptor research
• Prefilled 3ml flexipen delivery system
• Stabilised and pH-balanced formulation
• No reconstitution required
• Manufactured by Remedium Research

How to Use

• Attach a compatible sterile pen needle before use
• Prime the device if required according to leaflet instructions
• Select the desired amount based on research protocol
• Administer via subcutaneous route where applicable
• Store refrigerated between 2–8°C

How It Works

• Retatrutide is investigated for triple receptor pathway activity
• Research focuses on GLP-1, GIP and glucagon receptor mechanisms
• The flexipen system supports precision investigational dosing
• High-concentration format designed for advanced laboratory protocols

Recommended Research Pairings

• May complement broader metabolic research frameworks
• Often investigated alongside peptide and hormonal studies
• Can be included within advanced laboratory investigation protocols